Mechanistic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID) (R01) | Apply Online

FAQs: Mechanistic Basis of Diffuse White Matter Disease in VCID (R01) (RFA-NS-16-021)

What is the title and funding opportunity number for this grant?

The opportunity is titled "Mechanistic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID) (R01)" and the Funding Opportunity Number is RFA-NS-16-021.

Which agency is sponsoring this opportunity?

The sponsoring agency is HHS-NIH (listed as HHS-NIH11).

What type of grant mechanism is this?

This is an NIH R01 research grant, intended for substantial, multi-year projects that are hypothesis-driven and designed to test mechanistic cause-and-effect relationships.

What is the main scientific focus of this FOA?

The main focus is understanding the mechanistic basis of diffuse white matter disease that arises from vascular problems in the brain, and how those vascular-driven white matter injuries contribute to cognitive impairment and dementia within the broader VCID research area.

What does VCID mean in the context of this funding opportunity?

VCID stands for Vascular Contributions to Cognitive Impairment and Dementia. In this context, it refers to the idea that late-life cognitive impairment is often shaped not only by classic neurodegenerative changes but also by vascular pathology that damages brain tissue over time.

What does the FOA mean by "diffuse white matter disease" from vascular causes?

It refers to widespread injury and degeneration of white matter that is driven by vascular pathology, including the cumulative effects of multifocal, small, and silent infarcts. These injuries may be tiny and clinically subtle, but they can disrupt white matter tracts and brain networks over time.

What are "small" or "silent" infarcts, and why are they emphasized?

Small and silent infarcts are tiny ischemic injuries that may not produce obvious stroke symptoms. The FOA emphasizes them because their cumulative impact can gradually disrupt white matter pathways and contribute to cognitive decline and dementia.

What kinds of research approaches are being prioritized?

The FOA prioritizes hypothesis-driven, mechanistic studies that move beyond description and correlation. The goal is to pinpoint specific cellular and molecular processes responsible for vascular-origin white matter disease and its relationship to cognitive impairment.

What mechanisms and biological processes are highlighted as areas of interest?

Examples of processes of interest include vascular insufficiency, small vessel pathology, blood flow dysregulation, blood-brain barrier changes, inflammation, hypoxic-ischemic stress, glial responses, and related pathways that can lead to white matter degeneration and impaired cognition.

Why is the FOA focused on mechanistic studies rather than descriptive studies?

Because the stated goal is to identify cause-and-effect biological processes that explain how vascular pathology produces diffuse white matter injury and cognitive decline. Mechanistic findings are also more likely to reveal actionable intervention points for prevention or slowing of impairment.

What is the practical or long-term significance of this research area?

By clarifying how vascular problems drive white matter injury and cognitive decline, the research could identify intervention points that may help prevent or slow cognitive impairment tied to vascular brain injury.

What is the award ceiling for this opportunity?

The listed award ceiling is $500,000. As described in the opportunity summary, this typically refers to direct costs per year unless the full announcement specifies otherwise.

What research activity category does this fall under?

It is categorized as an NIH health research activity.

Which CFDA numbers are associated with this opportunity?

The opportunity is associated with CFDA numbers 93.853 and 93.866, reflecting NIH neuroscience and aging-related research areas relevant to VCID.

Who is eligible to apply?

Eligibility is broad and includes: state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (excluding higher education institutions in those specific nonprofit categories); for-profit organizations other than small businesses; small businesses; and other entities as clarified in the FOA.

Does this opportunity allow applications from for-profit organizations?

Yes. The eligibility list includes for-profit organizations other than small businesses as well as small businesses.

Can tribal governments or tribal organizations apply?

Yes. Federally recognized Native American tribal governments and other tribal organizations are listed as eligible applicants.

Can government entities apply?

Yes. State, county, and local governments, as well as special district governments and independent school districts, are included in the eligible applicant types.

When was this opportunity posted and created?

The opportunity was posted and created on February 3, 2016.

What was the closing date for applications?

The original and current closing date listed is April 19, 2016.

Is this opportunity still open based on the dates provided?

Based on the information provided, the closing date was April 19, 2016, indicating that this specific posting was tied to a 2016 deadline.

If the posting is from 2016, why might this information still be useful?

The description still provides a clear scientific framework for the kind of mechanistic VCID research NIH prioritized in this area: studies explaining how vascular pathology produces diffuse white matter injury and how that injury contributes to cognitive impairment and dementia, particularly through small, multifocal, and silent infarcts that accumulate over time.

What scale of project does an R01 typically imply for this FOA?

The R01 mechanism implies a substantial research effort with clearly articulated hypotheses, strong experimental design, and rigorous plans aimed at testing mechanistic relationships rather than only reporting associations.

Does the FOA specify particular disease outcomes of interest?

Yes. The FOA connects vascular-origin diffuse white matter injury to cognitive decline and dementia, emphasizing vascular contributions to cognitive impairment and dementia (VCID).

What kinds of brain changes are central to the FOA's aims?

The FOA centers on vascular pathology and the downstream effects on brain white matter, including how cumulative ischemic injuries and related vascular and inflammatory processes can lead to diffuse white matter degeneration and impaired cognition.